• Skip to primary navigation
  • Skip to content
  • Skip to primary sidebar
Gynesonics

Gynesonics

Advancing technology. Improving women's lives.

  • Our Company
    • About Us
    • Compliance and Quality
    • Careers
  • Our People
    • Management
    • Board of Directors
    • Investors
  • Our Technology
    • The Sonata System
    • Indications and Safety
    • Instructions for Use
    • Request for Medical or Scientific Information
  • Our News
    • Press Releases
    • In the News
    • Publications
  • Contact Us

Sonata Treatment

Gynesonics Announces New SMART OS™ Software Technology for Sonata® System Treatment of Uterine Fibroids

September 28, 2024

Revolutionizing Fibroid Treatment with Enhanced Precision, Control & Flexibility REDWOOD CITY, CA, September 26, 2024 – Gynesonics Inc., a medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today the launch of its new

First-of-its-Kind Uterine Fibroid Treatment Comes to UConn Health

August 4, 2024

A new, less costly, less invasive, and less time-consuming option for treating uterine fibroids is now available to the women of Connecticut. NBC Connecticut features a segment on the Sonata Treatment with insights from Dr. Jessie Jones and Dr. Amanda Urich of UConn Health. Watch the news segment

WNBC-NY – New Treatment to Help Women with Fibroids

August 4, 2024

Patient Lauren Mims shared her journey with fibroids on WNBC-NY. Struggling since age 17, Lauren faced ER visits, five surgeries, and three different medications before finding relief through transcervical uterine ablation. Dr. Tara Shirazian from NYU Langone performed the procedure and discussed

Incisionless fibroid treatment option now available in West Virginia

May 23, 2024

Stephen Bush, MD; Todd DePond, MD; Karinna Andrews, DO and Emily Montgomery, MD, with CAMC Obstetrics and Gynecology at Women and Children’s Hospital, are the only Ob-Gyn’s in West Virginia offering the Sonata® Treatment for women suffering from debilitating symptoms caused by uterine

Gynesonics Announces New Category 1 CPT Code for its Sonata Transcervical RF Ablation Procedure Used to Treat Uterine Fibroids

January 3, 2024

REDWOOD CITY, Calif., Jan. 02, 2024 (GLOBE NEWSWIRE) -- Gynesonics®, Inc. a privately-held women’s healthcare medical device company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced today that with the support of the American College of

How the Sonata Treatment Restored Quality of Life for a Patient with Uterine Fibroids

January 4, 2023

The side effects of uterine fibroids ruled Brandy Addis’s life. Brandy has a history of cramping and heavy periods that would last seven to 10 days. Over the last couple of years, her symptoms and experiences were worsening with her period occurring twice a month. The last few years were so awful

Transcervical Fibroid Ablation (Sonata Treatment) Mentioned on TODAY Show

July 28, 2022

Dr. Tara Shirazian, director of the Center for Fibroid Care at NYU Langone, joins the 3rd Hour of the TODAY show to discuss fibroid symptoms and treatment options including Transcervical Radiofrequency Ablation also known as Transcervical Fibroid Ablation (TFA) or the Sonata System. The Sonata

Uterine Fibroids Were No Match for Marilee

April 27, 2022

Marilee Calamas is a family nurse practitioner who was the picture of good health – except for her heavy periods caused by uterine fibroids, which made day-to-day activities impossible during her menstrual cycle. Fortunately, she was a candidate for [the Sonata treatment,] a minimally invasive

Primary Sidebar

  • Privacy Notice
  • Cookie Notice
  • Do Not Sell/Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information

© Copyright 2025 Gynesonics · All Rights Reserved · WS 05198 Rev. M

  • Privacy Notice
  • Cookie Notice
  • Do Not Sell/Share My Personal Information
  • Limit the Use of My Sensitive Personal Information
  • Terms of Use
  • Impressum
  • Patents
  • Safety Information